LONDON, 22 July 2021 - DeepMind today announced its partnership with the European Molecular Biology Laboratory (EMBL), Europe's flagship laboratory for the life sciences, to make the most complete and ...
EMBL scientists apply and develop AI tools in collaborative life science research in many different areas, from structural biology and image analysis to omics and technology development. The German AI ...
The tremors that shook the life sciences community last December were mere prelude. Back then, at a biennial protein-prediction competition, an artificial intelligence (AI) tool called AlphaFold ...
In January 2014, Judith Zaugg got a call from European Molecular Biology Laboratory (EMBL), a flagship for European basic research in the life sciences, funded by public research money from 21 member ...
Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports. Actionable insights into research performance. Detailed analysis of strengths and ...
A pioneering optical technique developed by the Prevedel Group at EMBL (the European Molecular Biology Laboratory, based in Heidelberg, Germany) allows neuroscientists to observe live neurons deep ...
EMBL Director General Edith Heard, Head of International Relations Plamena Markova and Chief Operating Officer Matti Tiirakari visited the University of Helsinki and FIMM at the end of May. FIMM, the ...
The European Molecular Biology Laboratory (EMBL) is running a data lake across two datacentre sites, based on NetApp storage, to support scientific research. Modern scientific research is heavily ...
Microfluidic tools have made recent biological and biomedical research leaps possible. At the interface of physics, engineering, chemistry, and biology, innovation in microfluidic approaches as ...
Mainz, 22 July 2025. Boehringer Ingelheim Stiftung commits 7 million euros to support the EMBL Imaging Centre in Heidelberg. A well-established EMBL partner, Boehringer Ingelheim Stiftung (BIS) is ...
£19.5M raised to drive development of best-in-class fully human VH antibody fragment therapeutics Crescendo Biologics Limited (Crescendo) today announces it has raised a further £2m ($3.3m), from EMBL ...
DeepMind is partnering with EMBL to make the most complete and accurate database yet of the predicted human protein structures freely and openly available to the scientific community. The AlphaFold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results